Physiological Role
Selenium is a trace element that the body incorporates as selenocysteine, a modified amino acid. This active form is a building block of 25 selenoproteins with distinct roles in antioxidant defence, hormonal regulation and cellular integrity.
Glutathione peroxidases (GPx) are the first major family of selenoproteins. They neutralise peroxides, oxidative molecules generated by normal cellular metabolism. This mechanism shields cell membranes and circulating lipids from oxidative damage. Mammals count eight glutathione peroxidases, five of which are selenoproteins, each active in a specific compartment (plasma, cytoplasm, gastrointestinal tract).
Thyroid deiodinases form the second family. They convert thyroxine (T4, the storage form) into triiodothyronine (T3, the active form), the hormone that regulates energy metabolism and thermogenesis. Thioredoxin reductase, a third major selenoprotein, supports the regeneration of intracellular antioxidant systems and DNA repair. Selenium therefore operates at three levels: oxidative defence, thyroid function and genomic integrity.
Reference Ranges
Depending on the biomarker, Singular ranges are based on a synthesis of nutritional or clinical reference points and longevity research. They do not replace your laboratory's reference values or your healthcare professional's advice.
Biological Significance
A serum selenium level within the optimal range reflects sufficient dietary intake to support selenoprotein activity.
Low values indicate intake that falls short of the body’s requirements. Several factors may explain this status: a diet low in selenium sources, impaired intestinal absorption or an ongoing inflammatory response, which lowers the measured concentration. The serum measurement reflects intake over the preceding weeks: after a change in intake, a steady state is reached in about ten weeks.
Elevated values may result from excessive supplementation or a particularly selenium-rich diet. A randomised trial in adults whose status was already high observed an increased incidence of type 2 diabetes at 200 micrograms per day. The relationship between selenium status and observed outcomes is described as U-shaped.
Regular monitoring of this marker tracks status over time. Combining it with other antioxidant markers, such as zinc and copper, provides a more complete picture of cellular defence capacity.
Influencing Factors
Diet. Dietary selenium comes primarily from Brazil nuts, fish, seafood, organ meats and eggs. The selenium content of plant foods depends directly on soil concentration. European soils are broadly lower in selenium than North American soils.
Geography. Average intakes vary considerably by region. In Western Europe, daily intakes often fall below recommended levels. In North America, selenium-rich soils ensure naturally higher intakes through the food chain.
Intestinal absorption. Organic forms of selenium (selenomethionine, selenocysteine) are absorbed more efficiently than inorganic forms (selenite, selenate). Chronic digestive conditions can reduce absorption and contribute to a low status.
Inflammation. Serum selenium falls during an inflammatory response, independently of intake. Across 2,217 samples from a reference laboratory, the median concentration drops by more than 40% from a C-reactive protein of 5 to 10 mg/L. This is why Singular reads selenium alongside hs-CRP.
Age. Selenium status tends to decline with age, linked to reduced dietary intake and lower absorption efficiency. Cohort studies observe lower concentrations at advanced ages.
Oxidative stress. Glutathione peroxidases carry selenium within their structure and are regenerated at each catalytic cycle. Sustained oxidative stress places greater demand on this defence system. Intense physical exercise, smoking and exposure to certain environmental pollutants increase that demand.
Supplementation. L-selenomethionine is the organic form chosen by Singular. It uses the same intestinal transporters as methionine, an essential amino acid. Dosing must remain calibrated: excess selenium can produce effects opposite to those intended.
Nutritional interactions. Zinc and copper participate in the same antioxidant defence network via superoxide dismutase. An imbalance in any of these trace elements can alter the overall efficiency of the system.
In the Singular Formula
Selenium is one of the markers whose serum level directly shapes the composition of the Singular formula. The formulation engine adjusts the selenium bioactive (L-selenomethionine) based on measured status.
When serum selenium falls within the low or very low ranges, the formula includes a reinforced dosage. The goal is to support a return toward a status compatible with optimal selenoprotein function. This adjustment requires hs-CRP to be no more than elevated: a very high hs-CRP suspends it, serum selenium becoming difficult to interpret. Targeted dietary guidance accompanies this adjustment to frame intake through food.
As soon as serum selenium reaches the optimal range, no rule adds any and the formula contains none. Additional intake on an already replete status would serve no purpose. This logic reflects the U-shaped relationship described between selenium status and observed outcomes.
Zinc and copper, also measured by Singular, participate in the same antioxidant defence network. Each of these markers opens its own rules. The selenium adjustment depends on its serum status and on hs-CRP.
Linked Bioactives
Scientific Studies
| Authors | Year | Type | Journal | |
|---|---|---|---|---|
| Rayman M.P. | 2012 | Review | The Lancet | View on PubMed |
Selenium and human health Landmark review on selenium and human health. Synthesises data on selenoprotein function and describes a U-shaped relationship between selenium status and observed outcomes. | ||||
| Vinceti M. et al. | 2018 | Meta-analysis | Cochrane Database of Systematic Reviews | View on PubMed |
Selenium for preventing cancer Cochrane meta-analysis evaluating the effect of selenium supplementation on cancer incidence. Available evidence does not support a protective effect of supplementation. | ||||
| Alehagen U. et al. | 2018 | Randomised Controlled Trial | PLoS One | View on PubMed |
Still reduced cardiovascular mortality 12 years after supplementation with selenium and coenzyme Q10 for four years Twelve-year follow-up of the KiSel-10 trial in 443 older adults in Sweden: after four years of selenium and coenzyme Q10 taken together, cardiovascular mortality was lower than with placebo. The authors regard this small study as preliminary, and its design cannot separate the contribution of either component. | ||||
| Rees K. et al. | 2013 | Meta-analysis | Cochrane Database of Systematic Reviews | View on PubMed |
Selenium supplementation for the primary prevention of cardiovascular disease Cochrane review on selenium supplementation and primary cardiovascular prevention. Evidence is insufficient to recommend supplementation in the general population. | ||||
| Lippman S.M. et al. | 2009 | Randomised Controlled Trial | JAMA | View on PubMed |
Effect of selenium and vitamin E on risk of prostate cancer and other cancers: the Selenium and Vitamin E Cancer Prevention Trial (SELECT) Randomised clinical trial in 35,533 men. Selenium supplementation alone or combined with vitamin E does not reduce prostate cancer risk. The hazard ratio for selenium alone is 1.04. | ||||
| Stranges S. et al. | 2007 | Randomised Controlled Trial | Annals of Internal Medicine | View on PubMed |
Effects of long-term selenium supplementation on the incidence of type 2 diabetes: a randomized trial Randomised trial showing increased type 2 diabetes incidence in participants supplemented with 200 micrograms per day of selenium. This finding illustrates the U-shaped curve principle and the need to calibrate intake. | ||||
| Bleys J. et al. | 2008 | Cohort Study | Archives of Internal Medicine | View on PubMed |
Serum selenium levels and all-cause, cancer, and cardiovascular mortality among US adults Cohort study analysing the relationship between serum selenium and mortality in US adults. Low selenium levels are associated with increased all-cause and cancer mortality. No association is found with cardiovascular mortality. | ||||